Literature DB >> 8139732

Creatol, a creatinine metabolite, as a useful determinant of renal function.

K Nakamura1, K Ienaga, K Nakano, M Nakai, Y Nakamura, G Hasegawa, M Sawada, M Kondo, H Mori, T Kanatsuna.   

Abstract

Analysis of creatol (CTL, 5-hydroxycreatinine), an oxidative creatinine (Cr) metabolite, in serum and urine of human subjects has indicated that CTL is a useful determinant of renal function. The existence itself of serum CTL (s-CTL) could be a diagnostic sign for chronic renal failure (CRF): in all normal subjects, s-CTL was undetectable, but s-CTL was detectable in sera of all patients with CRF (s-Cr: > 2.0 mg/dl). And the s-CTL values increased in proportion to the severity of CRF in such patients. Furthermore, the molar ratio (CTL/Cr) in both urine and serum increased significantly in proportion to the severity of CRF. Our results indicated not only hyperproduction of CTL but also higher oxygen stress in patients according to the progression of CRF. The diagnostic importance of the CTL value and the CTL/Cr ratio are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139732     DOI: 10.1159/000187791

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Inhibition by heparin of protein kinase C activation and hydroxyl radical generation in puromycin aminonucleoside treated isolated rat hepatocytes.

Authors:  Kazumasa Aoyagi; Yutaka Kuzure; Siranoush Shahrzad; Aki Hirayama; Sohji Nagase; Atsushi Ueda
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

2.  Acute kidney injury mediated by oxidative stress in Egyptian horses with exertional rhabdomyolysis.

Authors:  Maged R el-Ashker
Journal:  Vet Res Commun       Date:  2011-04-02       Impact factor: 2.459

3.  Evaluation of oxidative stress markers for the early diagnosis of allograft rejection in feline renal allotransplant recipients with normal renal function.

Authors:  Krista B Halling; Gary W Ellison; Don Armstrong; Kasumi Aoyagi; Carol J Detrisac; John P Graham; Susan P Newell; Frank G Martin; James M Van Gilder
Journal:  Can Vet J       Date:  2004-10       Impact factor: 1.008

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.